An Acute Randomized Controlled Trial of Noninvasive Peripheral Nerve Stimulation in Essential Tremor.


Journal

Neuromodulation : journal of the International Neuromodulation Society
ISSN: 1525-1403
Titre abrégé: Neuromodulation
Pays: United States
ID NLM: 9804159

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 12 09 2018
revised: 28 11 2018
accepted: 12 12 2018
pubmed: 1 2 2019
medline: 14 1 2020
entrez: 1 2 2019
Statut: ppublish

Résumé

To evaluate the safety and effectiveness of a wrist-worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single in-office session. This was a randomized controlled study of 77 ET patients who received either treatment stimulation (N = 40) or sham stimulation (N = 37) on the wrist of the hand with more severe tremor. Tremor was evaluated before and immediately after the end of a single 40-minute stimulation session. The primary endpoint compared spiral drawing in the stimulated hand using the Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS) Archimedes spiral scores in treatment and sham groups. Additional endpoints included TETRAS upper limb tremor scores, subject-rated tasks from the Bain and Findley activities of daily living (ADL) scale before and after stimulation as well as clinical global impression-improvement (CGI-I) rating after stimulation. Subjects who received peripheral nerve stimulation did not show significantly larger improvement in the Archimedes spiral task compared to sham but did show significantly greater improvement in upper limb TETRAS tremor scores (p = 0.017) compared to sham. Subject-rated improvements in ADLs were significantly greater with treatment (49% reduction) than with sham (27% reduction; p = 0.001). A greater percentage of ET patients (88%) reported improvement in the stimulation group as compared to the sham group (62%) according to CGI-I ratings (p = 0.019). No significant adverse events were reported; 3% of subjects experienced mild adverse events. Peripheral nerve stimulation in ET may provide a safe, well-tolerated, and effective treatment for transient relief of hand tremor symptoms.

Identifiants

pubmed: 30701655
doi: 10.1111/ner.12930
pmc: PMC6766922
pii: S1094-7159(21)01976-0
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

537-545

Subventions

Organisme : Cala Health, Inc.

Informations de copyright

© 2019 The Authors. Neuromodulation: Technology at the Neural Interface published by Wiley Periodicals, Inc. on behalf of International Neuromodulation Society.

Références

J Neurol Neurosurg Psychiatry. 1999 Jun;66(6):772-5
pubmed: 10329753
Mov Disord. 1999 Sep;14(5):847-50
pubmed: 10495050
N Engl J Med. 2000 Feb 17;342(7):461-8
pubmed: 10675426
J Hand Ther. 2000 Oct-Dec;13(4):276-88
pubmed: 11129253
Nervenarzt. 1954 Nov 20;25(11):441-7
pubmed: 14356288
Neurology. 2003 Dec 23;61(12):1804-6
pubmed: 14694055
Electromyogr Clin Neurophysiol. 1992 Jul-Aug;32(7-8):369-72
pubmed: 1526217
J Neurophysiol. 2004 Dec;92(6):3171-82
pubmed: 15295009
Can J Neurol Sci. 2004 Aug;31(3):333-42
pubmed: 15376477
Lancet Neurol. 2005 Feb;4(2):100-10
pubmed: 15664542
Lancet. 1991 Feb 16;337(8738):403-6
pubmed: 1671433
Brain. 2006 Oct;129(Pt 10):2660-6
pubmed: 16891320
J Neurophysiol. 2008 Sep;100(3):1610-21
pubmed: 18596185
Lancet Neurol. 2011 Feb;10(2):148-61
pubmed: 21256454
J Neurosurg. 2014 Jan;120(1):132-9
pubmed: 24236657
Mov Disord. 2014 May;29(6):838-42
pubmed: 24375570
Tremor Other Hyperkinet Mov (N Y). 2014 Aug 14;4:259
pubmed: 25157323
J Neurosci. 2015 Jan 14;35(2):795-806
pubmed: 25589772
Neurology. 1989 Dec;39(12):1587-8
pubmed: 2586774
J Neurosci. 2015 Jun 10;35(23):8925-37
pubmed: 26063924
Pain Ther. 2015 Oct 14;:null
pubmed: 26467451
Front Neurol. 2016 Apr 22;7:60
pubmed: 27148160
N Engl J Med. 2016 Aug 25;375(8):730-9
pubmed: 27557301
N Engl J Med. 2016 Aug 25;375(8):792-3
pubmed: 27557307
Front Neurosci. 2017 Apr 04;11:178
pubmed: 28420958
Parkinsonism Relat Disord. 2017 Aug;41:79-85
pubmed: 28576604
Mov Disord Clin Pract. 2015 Dec;2(4):384-387
pubmed: 28845438
Mayo Clin Proc. 2017 Sep;92(9):1427-1444
pubmed: 28870357
Mov Disord. 2018 Jan;33(1):179-180
pubmed: 29150859
Neurology. 1986 Jul;36(7):1001-4
pubmed: 2940473
Mov Disord. 2018 Jul;33(7):1182-1183
pubmed: 29663525
Front Neurol. 2018 Apr 19;9:257
pubmed: 29725318
N Engl J Med. 2018 May 10;378(19):1802-1810
pubmed: 29742376
J Neurol Neurosurg Psychiatry. 1987 Jun;50(6):704-8
pubmed: 3612150
Epilepsia. 1994 May-Jun;35(3):616-26
pubmed: 8026408
J Neurol Neurosurg Psychiatry. 1993 Oct;56(10):1085-9
pubmed: 8410007
Stat Med. 1996 Jul 15;15(13):1421-34
pubmed: 8841652
Ann Neurol. 1997 Sep;42(3):292-9
pubmed: 9307249
Mov Disord. 1998 Jan;13(1):5-10
pubmed: 9452318
Mov Disord. 1998;13 Suppl 3:2-23
pubmed: 9827589

Auteurs

Rajesh Pahwa (R)

University of Kansas Medical Center, Kansas City, KS, USA.

Rohit Dhall (R)

University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Jill Ostrem (J)

University of California San Francisco, San Francisco, CA, USA.

Ryder Gwinn (R)

Swedish Medical Center Seattle, Seattle, WA, USA.

Kelly Lyons (K)

University of Kansas Medical Center, Kansas City, KS, USA.

Susie Ro (S)

Swedish Medical Center Seattle, Seattle, WA, USA.

Cameron Dietiker (C)

University of California San Francisco, San Francisco, CA, USA.

Nijee Luthra (N)

University of California San Francisco, San Francisco, CA, USA.

Paula Chidester (P)

Cala Health, Inc., Burlingame, CA, USA.

Samuel Hamner (S)

Cala Health, Inc., Burlingame, CA, USA.

Erika Ross (E)

Cala Health, Inc., Burlingame, CA, USA.
Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.

Scott Delp (S)

Department of Bioengineering, Stanford University, Stanford, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH